DDrare: Database of Drug Development for Rare Diseases

Antioxidants (DrugBank: -)

3 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
90	網膜色素変性症	1
298	遺伝性膵炎	1
310	先天異常症候群	1

90. 網膜色素変性症　［臨床試験数：103，薬物数：158（DrugBank：42），標的遺伝子数：52，標的パスウェイ数：107］

Searched query = "Retinitis pigmentosa", "Rod dystrophy", "Rod-Cone Dystrophy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 103 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01773278 (ClinicalTrials.gov)	December 2008	3/12/2012	Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)	Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)	Smith-Lemli-Opitz Syndrome;Cone-Rod Dystrophy;Hearing Loss	Drug: Antioxidants;Drug: Cholesterol	University of Colorado, Denver	NULL	Recruiting	N/A	65 Years	All	100	Phase 2	United States

298. 遺伝性膵炎　［臨床試験数：93，薬物数：168（DrugBank：51），標的遺伝子数：48，標的パスウェイ数：134］

Searched query = "Hereditary pancreatitis", "Chronic pancreatitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 93 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00319358 (ClinicalTrials.gov)	October 2003	26/4/2006	Role of Antioxidants Supplementation in Chronic Pancreatitis	Effect of Antioxidant Supplementation on Pain, Antioxidant Profile and Oxidative Stress in Patients With Chronic Pancreatitis	Chronic Pancreatitis	Dietary Supplement: Antioxidants;Dietary Supplement: Placebo	All India Institute of Medical Sciences, New Delhi	NULL	Completed	12 Years	70 Years	Both	127	Phase 3	India

310. 先天異常症候群　［臨床試験数：10，薬物数：18（DrugBank：10），標的遺伝子数：3，標的パスウェイ数：7］

Searched query = "Congenital anomalies syndrome", "Trisomy 1q", "9q34 deletion syndrome", "Cornelia de Lange syndrome", "CdLS", "Smith-Lemli-Opitz syndrome", "SLO syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 10 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01773278 (ClinicalTrials.gov)	December 2008	3/12/2012	Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)	Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)	Smith-Lemli-Opitz Syndrome;Cone-Rod Dystrophy;Hearing Loss	Drug: Antioxidants;Drug: Cholesterol	University of Colorado, Denver	NULL	Recruiting	N/A	65 Years	All	100	Phase 2	United States